Stargazer Pharmaceuticals is based in Boston. It has raised $57M in total funding. Latest round: Series A.
Stargazer Pharmaceuticals is based in Boston. Stargazer Pharmaceuticals has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2020. The round record for Stargazer Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Novo Holdings, venBio Partners, Canaan Partners, Pontifax, Retinal Degeneration Fund. 5 distinct backers are named across the disclosed rounds.
Round data for Stargazer Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026